Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27511-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- JAB1 antibody
- Antibody type
- Polyclonal
- Description
- JAB1 antibody (Cat. #27511-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation.
JAB1/CRL4B complex represses PPARG/ACSL5 expression to promote breast tumorigenesis.
The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway.
PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
Crosslinking-mediated Interactome Analysis Identified PHD2-HIF1α Interaction Hotspots and the Role of PHD2 in Regulating Protein Neddylation.
Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
COP9 Signalosome Subunit 3 Restricts Neuroinflammatory Responses During Cerebral Ischemia/Reperfusion Injury Through Stabilizing Suppressor of Cytokine Signaling 3 Protein.
Identification of Key Transcription Factors and Immune Infiltration Patterns Associated With Breast Cancer Prognosis Using WGCNA and Cox Regression Analysis.
The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.
Hu H, Wang Q, Yu D, Tao X, Guo M, Tian S, Zhang Q, Xu M, Geng X, Zhang H, Xu H, Li L, Xie S, Chen K, Zhu W, Li XW, Xu H, Li B, Zhang W, Liu S
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(7):e2413122
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(7):e2413122
JAB1/CRL4B complex represses PPARG/ACSL5 expression to promote breast tumorigenesis.
Hu T, Ma T, Huo M, Liu J, Zhang D, Li Y, Chang J, Zhang M, Wang Y, Gao T, Yuan B, Wang S, Li Q, Ma X, Zhang J, Huang W, Wang Y
Cell death and differentiation 2025 Dec 12;
Cell death and differentiation 2025 Dec 12;
The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway.
Wang Y, Deng X, Xie J, Lu T, Qian R, Guo Z, Zeng X, Liao J, Ding Z, Zhou M, Niu X
Cell biology and toxicology 2024 Jun 12;40(1):45
Cell biology and toxicology 2024 Jun 12;40(1):45
PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
Li Q, Li J, Wang J, Wang J, Lu T, Jia Y, Sun H, Ma X
Molecular carcinogenesis 2024 Feb;63(2):253-265
Molecular carcinogenesis 2024 Feb;63(2):253-265
Crosslinking-mediated Interactome Analysis Identified PHD2-HIF1α Interaction Hotspots and the Role of PHD2 in Regulating Protein Neddylation.
Ouyang H, How CY, Wang X, Yu C, Luo A, Huang L, Chen Y
bioRxiv : the preprint server for biology 2024 Dec 17;
bioRxiv : the preprint server for biology 2024 Dec 17;
Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
Zhu P, Jin Z, Kang G, Jia Y, Liu D, Zhang Q, Guo F, Jia Y, Jiao Y, Li J, Sun H, Ma X
Cell communication and signaling : CCS 2022 Aug 15;20(1):121
Cell communication and signaling : CCS 2022 Aug 15;20(1):121
COP9 Signalosome Subunit 3 Restricts Neuroinflammatory Responses During Cerebral Ischemia/Reperfusion Injury Through Stabilizing Suppressor of Cytokine Signaling 3 Protein.
Liang E, Li X, Fu W, Zhao C, Yang B, Yang Z
Neuropsychiatric disease and treatment 2021;17:1217-1227
Neuropsychiatric disease and treatment 2021;17:1217-1227
Identification of Key Transcription Factors and Immune Infiltration Patterns Associated With Breast Cancer Prognosis Using WGCNA and Cox Regression Analysis.
Yin X, Liu J, Wang X, Yang T, Li G, Shang Y, Teng X, Yu H, Wang S, Huang W
Frontiers in oncology 2021;11:742792
Frontiers in oncology 2021;11:742792
The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells.
Zhang H, He P, Zhou Q, Lu Y, Lu B
Cancer cell international 2021 Jul 12;21(1):369
Cancer cell international 2021 Jul 12;21(1):369
No comments: Submit comment
No validations: Submit validation data